Compare uniQure N.V. Ordinary Shares (QURE) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs United Airlines Holdings Inc — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while United Airlines Holdings Inc trades at $98.93 (market cap $33.51B). The key difference: United Airlines Holdings Inc is far larger — about 22.6× uniQure N.V. Ordinary Shares's market cap, and United Airlines Holdings Inc is more actively traded (5,035,282 versus 2,488,780). Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and United Airlines Holdings Inc for 46 Days on average.
| QURE | UAL | |
|---|---|---|
Market Cap | $1.48B | $33.51B |
Volume | 2,488,780 | 5,035,282 |
Sector | Health | Industrials |
52-Week High | $70.59 | $136.11 |
52-Week Low | $9.03 | $85.21 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $728.62M | $50.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
United Airlines (UAL) stock trades at $98.96, down 5.25% on the day, reflecting near-term pressure. The company maintains strong fundamentals with a P/E of 9.67 and robust profitability, including a 5.56% net margin and 23.25% ROE. Recent earnings have consistently beaten estimates, and analysts project a consensus price target of $158.10. However, technical indicators signal a bearish trend, and cash flow turned negative in 2025 due to elevated capital expenditures.
The outlook for UAL is mixed. Strong earnings momentum, market share gains from aggressive customer acquisition, and attractive valuation multiples support upside potential. Key risks include volatile fuel costs, competitive intensity, and debt levels. With no sell ratings from analysts and institutional confidence, the stock presents a compelling opportunity for value-oriented investors despite near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
